Douche "complaints," demographics requested from industry in FDA letter.
This article was originally published in The Tan Sheet
Executive Summary
VAGINAL DOUCHE USE PATTERNS, COMPLAINT INFO REQUESTED BY FDA in a Feb. 19 letter to industry from Division of OTC Drug Products Director Debra Bowen, MD. The letter was issued to solicit information in preparation for the April 15 joint meeting of FDA's Nonprescription Drugs, Anti-Infective Drugs and Reproductive Drugs Advisory Committees, along with participants from the Center for Devices & Radiological Health ("The Tan Sheet" Feb. 17, p. 3).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning